+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transfection Technologies Market - Global Forecast to 2030- Product Image
Transfection Technologies Market - Global Forecast to 2030- Product Image
Sale

Transfection Technologies Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716093
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transfection Technologies Market grew from USD 1.26 billion in 2024 to USD 1.37 billion in 2025. It is expected to continue growing at a CAGR of 8.60%, reaching USD 2.08 billion by 2030.

The field of transfection technologies stands at the forefront of molecular and cellular research, empowering breakthroughs in gene therapy, vaccine development and protein expression. Driven by the imperative to deliver genetic material into living cells with high efficiency and minimal cytotoxicity, transfection methods have evolved significantly over the past decade. Researchers and industry leaders are leveraging advanced reagent formulations, innovative physical delivery mechanisms and sophisticated instrumentation to address challenges in transfection efficiency, target specificity and scalability. As applications expand from fundamental cell line development to cutting-edge CRISPR gene editing, the market’s trajectory reflects a growing demand for customizable, high-throughput solutions. Furthermore, strategic partnerships between reagent providers and instrument manufacturers are fostering integrated platforms that streamline workflows and accelerate discovery. This executive summary provides a concise yet comprehensive overview of the market landscape, highlighting transformative shifts, regulatory headwinds, segmentation nuances, regional dynamics and competitive positioning. By synthesizing these insights, decision-makers can navigate emerging opportunities, anticipate supply chain disruptions and refine their strategic roadmaps to maintain a leading edge in an increasingly competitive arena.

Transformative Shifts Redefining Transfection Landscape

The past few years have witnessed transformative shifts reshaping the transfection landscape. Foremost, the rise of CRISPR and gene editing platforms has propelled demand for high-precision delivery methods, prompting reagent manufacturers to innovate novel formulations that enhance cellular uptake of ribonucleoproteins and nucleic acids. Concurrently, the integration of microfluidic and nanofluidic technologies into transfection instruments has elevated throughput and reproducibility, enabling large-scale screens and automated workflows. Advances in physical transfection-such as refined electroporation protocols and next-generation gene gun systems-now offer customizable energy parameters that minimize cell damage and maximize viability. In parallel, machine learning algorithms are being deployed to optimize reagent combinations and delivery parameters in silico, reducing experimental iterations and accelerating time to insight. Collaboration between biotech startups and established players has expanded the availability of prevalidated transfection kits tailored to emerging cell models, including primary and stem cells. Altogether, these developments mark a shift from one-size-fits-all protocols toward data-driven, application-specific solutions that cater to the nuanced demands of modern life science research and therapeutic development.

Cumulative Impact of U.S. Tariffs in 2025 on Market Dynamics

In 2025, newly implemented United States tariffs on select laboratory equipment and imported chemical reagents are exerting a cumulative impact on the transfection market. Increased duties on microfluidic chips and electroporation cuvettes have elevated instrument acquisition costs, compelling core facilities to reassess capital investments and extend equipment lifecycles through preventive maintenance. At the same time, higher import levies on specialized lipofection reagents and viral vector kits are translating into escalated per-experiment expenses, prompting researchers to optimize experimental designs and reduce reagent consumption. These cost pressures have spurred reagent manufacturers to explore domestic production partnerships and to diversify supply chains by sourcing raw materials from tariff-exempt regions. Meanwhile, instrument vendors are accelerating product localization strategies and negotiating supply agreements that mitigate duty burdens. Although short-term margins may contract, these adaptations are catalyzing industry resilience and fostering a more robust, geographically diversified supply network. Stakeholders who proactively realign procurement strategies and engage in collaborative forecasting with vendors will be best positioned to navigate the evolving tariff landscape and safeguard research continuity.

Key Segmentation Insights Across Products, Methods, Applications, and End-Users

A granular segmentation analysis reveals critical insights across four dimensions. The product dimension differentiates the market between high-precision instruments and versatile reagents & kits, with strong investments in automated transfection workstations complementing demand for ready-to-use lipid and polymer formulations. Methodology segmentation underscores three principal modalities: biological transfection relying on plasmid DNA and viral vectors to achieve targeted gene delivery; chemical transfection encompassing calcium phosphate protocols and lipofection reagents designed for ease-of-use in high-throughput contexts; and physical transfection methods-biolistic gene guns, electroporation systems and microinjection platforms-that address challenges in hard-to-transfect cell types. Application segmentation elucidates five core use cases: cell line development for foundational research, CRISPR & gene editing applications driving next-generation therapy design, gene therapy pipelines targeting rare disorders, large-scale protein production for biologics manufacturing and vaccination platforms requiring rapid antigen expression. Finally, end-user segmentation highlights four key customer groups: academic & research institutes pursuing basic science objectives, contract research organizations delivering outsourced discovery services, hospitals & diagnostic laboratories integrating transfection into translational workflows and pharmaceutical & biotechnology companies scaling development of novel therapeutics.

Key Regional Insights: Americas, EMEA, and Asia-Pacific Trends

Regional dynamics reveal divergent growth trajectories and strategic priorities. In the Americas, robust funding for gene therapy and vaccine initiatives is driving demand for both high-throughput reagent kits and advanced transfection instruments, supported by government grants and private investment. Meanwhile, the Europe, Middle East & Africa region combines stringent regulatory frameworks with burgeoning research hubs in Western Europe and the Gulf, prompting suppliers to secure CE-marked reagents and to establish regional service centers. Across the Asia-Pacific landscape, rapid expansion of biotech clusters in China, Japan and India is fueling adoption of cost-effective chemical transfection reagents, even as emerging markets in Southeast Asia explore partnerships to access premium electroporation platforms. Cross-regional collaborations are also materializing, as manufacturers leverage global distribution networks to mitigate supply disruptions and to tailor product portfolios to localized research needs. Taken together, these regional insights underscore the importance of a nuanced go-to-market strategy that aligns product offerings with diverse regulatory, infrastructural and investment climates.

Key Company Insights Driving Innovation and Competition

An analysis of leading players underscores a competitive yet collaborative ecosystem. Legacy instrument providers such as Agilent Technologies, Inc. and Bio-Rad Laboratories, Inc. continue to refine electroporation systems and microfluidic transfection modules, while reagents specialists like Promega Corporation, Qiagen NV and Thermo Fisher Scientific, Inc. innovate novel lipid nanoparticle and polymer formulations. At the same time, nimble biotechnology firms-including Akron Biotech LLC, Altogen Biosystems and GeneCopoeia Inc.-are carving niche positions in viral vector and plasmid DNA solutions. Cross-sector alliances are evident between FUJIFILM Wako Pure Chemical Corporation and MaxCyte Inc., focusing on scalable platform integration, whereas Horizon Discovery Group plc by PerkinElmer, Inc. leverages CRISPR-edited cell lines in conjunction with bespoke transfection kits. Other notable contributors-such as Merck KGaA, Bioneer Corporation and Takara Bio Inc.-are advancing next-generation delivery vehicles and reagent chemistries, and specialty vendors like Polyplus-transfection SA by Sartorius AG and OZ Biosciences SAS address complex applications in primary and stem cell models. Collectively, this dynamic landscape reflects a balance between established brands driving incremental innovation and emerging firms challenging the status quo through agile development cycles.

Actionable Recommendations for Industry Leaders in Transfection Technologies

To stay ahead in a rapidly evolving market, industry leaders should prioritize three strategic imperatives. First, invest in modular, data-driven platforms that integrate machine learning algorithms to optimize transfection parameters in real time and reduce experimental variability. Second, cultivate diversified, tariff-resilient supply chains by negotiating localized manufacturing partnerships and exploring duty-free sourcing options for critical reagents and instrument components. Third, deepen cross-sector collaborations by co-developing prevalidated reagent-instrument bundles with academic consortia and contract research organizations, thereby accelerating adoption and creating stickier customer relationships. Additionally, enhance service offerings by providing on-demand technical support, virtual training modules and digital protocol libraries to reduce onboarding time for novel transfection workflows. Finally, monitor evolving regulatory landscapes-particularly in gene therapy and cell therapy applications-to ensure compliance and to preempt market access barriers. By aligning product roadmaps with these priorities, organizations can fortify their competitive positioning and drive sustainable growth in the transfection technologies arena.

Conclusion: Navigating the Future of Transfection

The transfection technologies market is at an inflection point, shaped by regulatory shifts, tariff pressures and technological breakthroughs. As instruments become more automated and reagents more specialized, stakeholders must embrace data-centric methodologies and agile operational models to capture emerging opportunities. Segmentation analysis reveals that success hinges on offering tailored solutions across distinct product, method, application and end-user segments. Regional strategies must be refined to address funding disparities, regulatory heterogeneity and infrastructure maturity in the Americas, EMEA and Asia-Pacific. Meanwhile, competitive dynamics underscore the value of strategic partnerships that foster co-innovation between established multinationals and disruptive startups. By following a clear strategic roadmap-one that emphasizes platform integration, supply chain robustness and customer-centric services-organizations can navigate market complexities and deliver transformative solutions that drive the next wave of discoveries in gene editing, gene therapy and beyond.

Market Segmentation & Coverage

This research report categorizes the Transfection Technologies Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Instruments
  • Reagents & Kits
  • Biological Transfection
    • Plasmid DNA
    • Viral Vectors
  • Chemical Transfection
    • Calcium Phosphate Transfection
    • Lipofection
  • Physical Transfection
    • Biolistic Transfection/Gene Guns
    • Electroporation
    • Microinjection
  • Cell Line Development
  • CRISPR & Gene Editing
  • Gene Therapy
  • Protein Production
  • Vaccination
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies

This research report categorizes the Transfection Technologies Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Transfection Technologies Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Agilent Technologies, Inc.
  • Akron Biotech LLC
  • Altogen Biosystems
  • Bio-Rad Laboratories, Inc.
  • Biomol GmbH
  • Bioneer Corporation
  • Epoch Life Science, Inc.
  • FUJIFILM Wako Pure Chemical Corporation
  • GeneCopoeia Inc.
  • Geno Technology, Inc.
  • Horizon Discovery Group plc by PerkinElmer, Inc.
  • Lonza Group
  • Maxcyte Inc.
  • Merck KGaA
  • Nepa Gene Co., Ltd.
  • OriGene Technologies, Inc.
  • OZ Biosciences SAS
  • Polyplus-transfection SA by Sartorius AG
  • Polysciences, Inc.
  • Promega Corporation
  • Qiagen NV
  • Reprocell Inc.
  • SignaGen Laboratories LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising awareness of RNA interference and gene editing techniques globally
5.1.1.2. Growing focus on personalized medicine and targeted gene therapies for complex disorders
5.1.1.3. Increasing global research funding in gene therapy and cellular biology applications
5.1.2. Restraints
5.1.2.1. High cost of advanced transfection reagents and lack of standardized protocols
5.1.3. Opportunities
5.1.3.1. Surging investments & funding to advance transfection technologies
5.1.3.2. Technological advancements in transfection reagent formulations to improve efficiency
5.1.4. Challenges
5.1.4.1. Stringent regulatory hurdles and safety compliance issues affecting the approval of new gene therapies
5.2. Market Segmentation Analysis
5.2.1. Product: Rising demand of reagents & kits for routine applications
5.2.2. End-User: Growing use of transfection technologies in academic & research institutes
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Transfection Technologies Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents & Kits
7. Transfection Technologies Market, by Method
7.1. Introduction
7.2. Biological Transfection
7.2.1. Plasmid DNA
7.2.2. Viral Vectors
7.3. Chemical Transfection
7.3.1. Calcium Phosphate Transfection
7.3.2. Lipofection
7.4. Physical Transfection
7.4.1. Biolistic Transfection/Gene Guns
7.4.2. Electroporation
7.4.3. Microinjection
8. Transfection Technologies Market, by Application
8.1. Introduction
8.2. Cell Line Development
8.3. CRISPR & Gene Editing
8.4. Gene Therapy
8.5. Protein Production
8.6. Vaccination
9. Transfection Technologies Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations (CROs)
9.4. Hospitals & Diagnostic Laboratories
9.5. Pharmaceutical & Biotechnology Companies
10. Americas Transfection Technologies Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Transfection Technologies Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Transfection Technologies Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. Duoning Biotechnology Group and Branca Bunús collaborate to optimize transient transfection processes for enhanced biopharmaceutical production solutions
13.3.2. STEMCELL Technologies introduces CellPore Transfection System to transform cell transfection and accelerate research in gene therapies and cancer treatments
13.3.3. Merck’s signs an agreement to acquire Mirus Bio to strengthen transfection technologies and accelerates viral vector-based gene therapy manufacturing
13.3.4. Polyplus Launches FectoVIR-LV Transfection Reagent with New DOE Service Options
13.3.5. BioCentriq and Kytopen Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing
13.3.6. Avectas Launches the Solupore Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. TRANSFECTION TECHNOLOGIES MARKET MULTI-CURRENCY
FIGURE 2. TRANSFECTION TECHNOLOGIES MARKET MULTI-LANGUAGE
FIGURE 3. TRANSFECTION TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 4. TRANSFECTION TECHNOLOGIES MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2024 VS 2030 (%)
FIGURE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TRANSFECTION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TRANSFECTION TECHNOLOGIES MARKET DYNAMICS
TABLE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CALCIUM PHOSPHATE TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY LIPOFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLISTIC TRANSFECTION/GENE GUNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CRISPR & GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 59. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 60. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 61. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 62. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 66. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 68. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 96. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 97. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 98. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 99. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 103. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 104. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 105. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 106. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 117. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 118. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 119. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 120. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 159. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 160. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 161. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 162. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 179. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 181. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 183. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 184. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 188. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 189. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 190. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 191. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 195. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 197. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 202. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 204. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 209. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 211. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 212. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 223. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 224. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 225. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 226. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 244. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 251. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 252. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 253. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 254. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 258. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 259. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 260. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 261. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 286. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 287. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 288. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 289. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 305. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 306. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 307. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 308. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 309. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 310. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TAB

Companies Mentioned

  • Agilent Technologies, Inc.
  • Akron Biotech LLC
  • Altogen Biosystems
  • Bio-Rad Laboratories, Inc.
  • Biomol GmbH
  • Bioneer Corporation
  • Epoch Life Science, Inc.
  • FUJIFILM Wako Pure Chemical Corporation
  • GeneCopoeia Inc.
  • Geno Technology, Inc.
  • Horizon Discovery Group plc by PerkinElmer, Inc.
  • Lonza Group
  • Maxcyte Inc.
  • Merck KGaA
  • Nepa Gene Co., Ltd.
  • OriGene Technologies, Inc.
  • OZ Biosciences SAS
  • Polyplus-transfection SA by Sartorius AG
  • Polysciences, Inc.
  • Promega Corporation
  • Qiagen NV
  • Reprocell Inc.
  • SignaGen Laboratories LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Transfection Reagents & Equipment Market - Global Forecast to 2030 - Product Image

Transfection Reagents & Equipment Market - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report, By Product, By Method (Electroporation), By Application (Transgenic Models), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report, By Product, By Method (Electroporation), By Application (Transgenic Models), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Transfection Technologies Market Report by Product Type, Application, Transfection Method, Technology, End-User, and Region 2025-2033 - Product Image

Transfection Technologies Market Report by Product Type, Application, Transfection Method, Technology, End-User, and Region 2025-2033

  • Report
  • 147 Pages
  • Global
From
Transfection Reagents and Equipment Market Report by Product, Technology, Application, End User, and Region 2025-2033 - Product Image

Transfection Reagents and Equipment Market Report by Product, Technology, Application, End User, and Region 2025-2033

  • Report
  • 138 Pages
  • Global
From
Viral Vector & Plasmid DNA Manufacturing Market by Type, Cell Line, Transfection, Indication, Workflow, Application, End User - Global Forecast 2025-2030 - Product Image

Viral Vector & Plasmid DNA Manufacturing Market by Type, Cell Line, Transfection, Indication, Workflow, Application, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From

About the Transfection Market

The Transfection market is a subset of the Genomics industry that focuses on the delivery of genetic material into cells. Transfection is a process that enables researchers to study gene function, gene expression, and gene regulation. It is used in a variety of applications, including gene therapy, drug discovery, and gene editing. Transfection reagents, such as plasmids, viral vectors, and liposomes, are used to deliver genetic material into cells. Transfection reagents are also used to study gene expression, gene regulation, and gene function. The Transfection market is highly competitive, with a number of companies offering a variety of products and services. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, Promega Corporation, Lonza Group, and Agilent Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.